Searched for
MYLAN STRIDES
Potential future growth in pharma space and in the generic space, says Deepak Shenoy, Capital MindStrides shot up quite a bit and some of it is on the back of FDA approvals for one of a new drug that it is starting to manufacture and als...11 Jun, 2014, 11.55 AM IST- Goldman Sachs sells 4.2 lakh Strides shares for Rs 36.8 croreGoldman Sachs Investments Mauritius, a shareholder of Strides Arcolab, today sold 4.2 lakh shares of the drug company for Rs 36.81 crore in...10 Dec, 2013, 08.07 PM IST
- Strides to pay dividend of Rs 500 per share post Agila saleArcolab said it will pay a special dividend of Rs 500 per equity share following the completion of its sale of Agila Specialties division t...10 Dec, 2013, 02.48 PM IST
- Goldman Sachs sells Strides Arcolab shares for Rs 33.4 croreGoldman Sachs Investments Mauritius today sold 3.80 lakh shares of drug major Strides Arcolab for nearly Rs 33.4 crore in open market.06 Dec, 2013, 08.00 PM IST
- Strides Arcolab plunges over 15% on completion of Agila saleThe pharmaceutical company said it has completed sale of its Agila Specialties Division to Mylan Inc for a total consideration of up to $1....05 Dec, 2013, 03.15 PM IST
- Strides completes $1.75 billion sale of Agila Specialties to MylanStrides Arcolab said it has completed the sale of its Agila Specialties division to Mylan Inc for a total consideration of up to $1.75 bill...05 Dec, 2013, 02.22 PM IST
- Mylan’s Agila Specialties deal faces riders from US watchdogUS-based generic giant Mylan Inc’s $1.85-billion bid to acquire Indian drugmaker Agila Specialties now faces fresh riders, this time from i...28 Sep, 2013, 04.00 AM IST
- USFDA warning letter to Agila not to affect acquisition: MylanMylan said the USFDA warning letter to Agila Specialties over violation of manufacturing norms in one of its plants will not affect the Rs ...17 Sep, 2013, 06.02 PM IST
- Govt clears Mylan's Rs 5,168-cr deal to acquire Agila SpecialtiesThe decision was taken at a meeting of the Cabinet Committee of Economic Affairs held, Information and Broadcasting Minister Manish Tiwari ...03 Sep, 2013, 08.06 PM IST
- Strides Arcolab surges over 7 pc as FIPB clears Mylan's FDI proposalSince Mylan's investment proposal is of over Rs 1,200 crore, it will go to the Cabinet Committee on Economic Affairs for final approval.28 Aug, 2013, 02.18 PM IST
- FIPB clears US pharma major Mylan's Rs 5,168 crore FDI proposalUS-based Mylan Inc's Rs 5,168 crore proposal to acquire Agila Specialties Pvt Ltd -- a subsidiary of pharma firm Strides Arcolab -- was cle...27 Aug, 2013, 06.29 PM IST
- CCI gives green signal to Strides Arcolab-Mylan dealCCI has approved the acquisition of a Strides Arcolab subsidiary by Mylan, saying the deal will not have an adverse impact on competition i...25 Jun, 2013, 03.12 PM IST
- Strides Arcolab sells drug injectible business for Rs 9000 crore to MylanThe purchase values Agila at 18.7 times December 2012 operating profit of $86 million and seven times its sales of $255 million.01 Mar, 2013, 05.00 AM IST
- Strides Arcolab sells Agila Specialities to Mylan for $1600Pharmaceutical company Strides Arcolab will sell its specialities division, Agila Specialities to Mylan for $1600 million in cash and a pot...28 Feb, 2013, 05.57 PM IST
- Mylan in exclusive talks to buy Strides Arcolab’s injectables unitStrides Arcolab and Mylan are in exclusive talks for the deal on Strides’ injectables unit, Agila Specialties, in a deal close to $2 billion15 Feb, 2013, 03.13 PM IST
- Pfizer eyes buyout of Strides Arcolab unit AgilaPfizer is among the companies weighing a purchase of the injectable-medicines unit of Indian drug supplier Strides Arcolab.25 Jan, 2013, 12.04 PM IST
- Strides, Orchid may see stake rejigAfter the high-profile Mylan-Matrix deal, private equity firms are emerging as major catalysts in domestic pharma M&As.21 Sep, 2006, 12.26 AM IST
Load More
